Actual immune-competent AML mouse models are based on the transplantation of transduced cells with fusion genes (RUNX1-ETO(9a), CBFB-MYH11, MLL-AF9) or their expression after transgenesis, conditional knock-in or chromosomal translocation. This evidence concerns the gene RUNX1 and acute myeloid leukemia.